Retension Pharmaceuticals, Inc. (NasdaqCM: RTSN)
Health Care · Pharmaceuticals · US
$12.27
+0.16% today · +16.5% 1Y
Retension Pharmaceuticals, Inc. (NasdaqCM: RTSN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $102.23M and employs 12 people.
Over the last twelve months the share price has gained 16.5%, trading between 9.66 and 18.64.
Tweenvest scores Retension Pharmaceuticals, Inc. across four factors: quality 51/100, value 100/100. Its strongest factor is value.
RTSN price history
Key figures
- Market cap
- $102.23M
- Revenue (TTM)
- —
- P/E
- -8.56
- EPS
- -14.81
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $18.64
- 52-week low
- $9.66
- Avg volume (3M)
- —
- Shares outstanding
- 8.33M
- Employees
- 12
- Next earnings
- —
About Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA.
- ISIN
- US76135H1005
- Founded
- 2023
- Listed since
- Oct 9, 2026
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Asiatic Laboratories LimitedDSE: ASIATICLAB | $104.89M | Tk107.30 | +2.88% |
| Journey Medical CorporationNasdaqCM: DERM | $104.15M | $3.69 | -5.38% |
| Organigram Global Inc.TSX: OGI | $102.49M | CA$1.04 | -11.86% |
| Semnur Pharmaceuticals, Inc.OTCPK: SMNR | $102.32M | $0.47 | +42.42% |
| Curatis Holding AGSWX: CURN | $101.48M | CHF16.00 | -4.76% |
| LENZ Therapeutics, Inc.NasdaqGS: LENZ | $100.86M | $3.21 | -7.76% |
| Themis Medicare LimitedBSE: 530199 | $99.14M | Rs101.50 | -0.61% |
| The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding CompanyASE: JPHM | $98.68M | JD1.54 | 0.00% |